Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer

NCT03557918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Tremelimumab

Sponsor

Matthew Galsky

Collaborators

[object Object]